Tortoise Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,661
| Closed | -$93.3K | – | 1099 |
|
|
2025
Q3 | $93.3K | Buy |
3,661
+99
| +3% | +$2.44K | 0.01% | 320 |
|
|
2025
Q2 | $86.3K | Sell |
3,562
-333
| -9% | -$7.77K | 0.01% | 313 |
|
|
2025
Q1 | $98.7K | Sell |
3,895
-215
| -5% | -$5.63K | 0.01% | 289 |
|
|
2024
Q4 | $109K | Sell |
4,110
-115
| -3% | -$3.12K | 0.01% | 294 |
|
|
2024
Q3 | $122K | Buy |
4,225
+145
| +4% | +$4.23K | 0.01% | 285 |
|
|
2024
Q2 | $114K | Buy |
4,080
+629
| +18% | +$17.3K | 0.01% | 280 |
|
|
2024
Q1 | $95.8K | Buy |
3,451
+7
| +0.2% | +$194 | 0.01% | 299 |
|
|
2023
Q4 | $99.1K | Sell |
3,444
-2,382
| -41% | -$72K | 0.01% | 275 |
|
|
2023
Q3 | $193K | Sell |
5,826
-474
| -8% | -$16.8K | 0.03% | 197 |
|
|
2023
Q2 | $231K | Buy |
6,300
+350
| +6% | +$13.6K | 0.03% | 181 |
|
|
2023
Q1 | $243K | Hold |
5,950
| – | – | 0.04% | 175 |
|
|
2022
Q4 | $305K | Buy |
5,950
+170
| +3% | +$8.15K | 0.05% | 162 |
|
|
2022
Q3 | $253K | Buy |
5,780
+1,455
| +34% | +$70.7K | 0.05% | 163 |
|
|
2022
Q2 | $227K | Buy |
4,325
+400
| +10% | +$20.4K | 0.04% | 166 |
|
|
2022
Q1 | $203K | Buy |
3,925
+80
| +2% | +$4.15K | 0.04% | 178 |
|
|
2021
Q4 | $227K | Buy |
3,845
+50
| +1% | +$2.48K | 0.04% | 157 |
|
|
2021
Q3 | $163K | Sell |
3,795
-1,275
| -25% | -$56.5K | 0.03% | 172 |
|
|
2021
Q2 | $199K | Hold |
5,070
| – | – | 0.04% | 158 |
|
|
2021
Q1 | $184K | Buy |
5,070
+104
| +2% | +$3.69K | 0.04% | 155 |
|
|
2020
Q4 | $183K | Sell |
4,966
-163
| -3% | -$5.98K | 0.04% | 149 |
|
|
2020
Q3 | $179K | Hold |
5,129
| – | – | 0.04% | 146 |
|
|
2020
Q2 | $159K | Sell |
5,129
-161
| -3% | -$5.47K | 0.04% | 150 |
|
|
2020
Q1 | $164K | Sell |
5,290
-1,281
| -19% | -$43.6K | 0.05% | 143 |
|
|
2019
Q4 | $244K | Buy |
6,571
+743
| +13% | +$26.5K | 0.06% | 126 |
|
|
2019
Q3 | $199K | Sell |
5,828
-2,334
| -29% | -$84.9K | 0.05% | 139 |
|
|
2019
Q2 | $335K | Buy |
8,162
+472
| +6% | +$18.7K | 0.08% | 117 |
|
|
2019
Q1 | $310K | Sell |
7,690
-629
| -8% | -$25.2K | 0.08% | 113 |
|
|
2018
Q4 | $345K | Sell |
8,319
-1,160
| -12% | -$48.2K | 0.09% | 110 |
|
|
2018
Q3 | $396K | Hold |
9,479
| – | – | 0.1% | 105 |
|
|
2018
Q2 | $326K | Buy |
9,479
+633
| +7% | +$21.6K | 0.09% | 118 |
|
|
2018
Q1 | $298K | Buy |
8,846
+451
| +5% | +$15.5K | 0.08% | 120 |
|
|
2017
Q4 | $288K | Sell |
8,395
-40
| -0.5% | -$1.36K | 0.08% | 119 |
|
|
2017
Q3 | $286K | Buy |
8,435
+2,635
| +45% | +$84.7K | 0.09% | 114 |
|
|
2017
Q2 | $185K | Sell |
5,800
-351
| -6% | -$11.1K | 0.06% | 124 |
|
|
2017
Q1 | $200K | Buy |
6,151
+74
| +1% | +$2.33K | 0.07% | 112 |
|
|
2016
Q4 | $187K | Buy |
6,077
+3,826
| +170% | +$117K | 0.06% | 111 |
|
|
2016
Q3 | $72K | Hold |
2,251
| – | – | 0.02% | 164 |
|
|
2016
Q2 | $75K | Hold |
2,251
| – | – | 0.03% | 164 |
|
|
2016
Q1 | $63K | Sell |
2,251
-1,313
| -37% | -$37.5K | 0.02% | 178 |
|
|
2015
Q4 | $109K | Sell |
3,564
-263
| -7% | -$8.27K | 0.04% | 139 |
|
|
2015
Q3 | $114K | Sell |
3,827
-300
| -7% | -$9.62K | 0.04% | 133 |
|
|
2015
Q2 | $131K | Buy |
4,127
+317
| +8% | +$10.3K | 0.05% | 137 |
|
|
2015
Q1 | $126K | Buy |
3,810
+587
| +18% | +$18.7K | 0.05% | 137 |
|
|
2014
Q4 | $95K | Buy |
3,223
+306
| +10% | +$8.77K | 0.04% | 162 |
|
|
2014
Q3 | $82K | Sell |
2,917
-1,677
| -37% | -$47.1K | 0.03% | 169 |
|
|
2014
Q2 | $129K | Buy |
4,594
+2,706
| +143% | +$77.1K | 0.05% | 127 |
|
|
2014
Q1 | $58K | Buy |
+1,888
| New | +$56.3K | 0.03% | 182 |
|
|
2013
Q4 | – | Sell |
-791
| Closed | -$22K | – | 374 |
|
|
2013
Q3 | $22K | Buy |
791
+214
| +37% | +$5.82K | 0.01% | 196 |
|
|
2013
Q2 | $15K | Buy |
+577
| New | +$15.9K | 0.01% | 204 |
|
Other funds holding PFE
Tortoise Investment Management's PFE Position: Q4 2025 in Review
Tortoise Investment Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 3,661 shares — an estimated $93.3K sold.
Tortoise Investment Management first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $396K in Q3 2018. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Tortoise Investment Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 3,661 Pfizer shares in Q4 2025, an estimated $93.3K.
- Tortoise Investment Management first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
- Tortoise Investment Management's Pfizer position peaked at $396K in Q3 2018.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.